Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MRC Technology
Biotech
LifeArc makes $30M Kymab investment to access antibody tech
The exchange gives Kymab a cash boost and way to expand use of the platforms beyond its current capacity as it prepares to list in the U.S.
Nick Paul Taylor
Jun 24, 2019 8:26am
LifeArc, née MRC Technology, sets up high-risk seed fund
Jun 14, 2017 7:01pm
Newsummit Biopharma licenses hepatitis C antibody from charity group
Mar 15, 2017 12:49pm
MRCT offloads Keytruda royalty rights to DRI, raising $150M for new research
Jul 15, 2016 2:42am
